Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Its key feature is enhancing natural GLP-1 hormone activity, which helps users feel fuller while maintaining digestive comfort
A 10 mg total blend mixed with 2 mL water equals 50 mcg total blend per U-100 syringe unit
The anti-obesity medication (AOM) marketplace is rapidly expanding, with analysts estimating it to be worth $150 billion by 2032, fueled by the increasing demand for effective weight management (e.g., 15-25% weight loss) and metabolic health solutions
For example, an HFpEF phenotype characterised by pronounced expansion of epicardial adipose tissue (EAT) has been suggested (Yang et al., 2013
This change only applies to weight loss drugs (e.g., GLP-1 and non-GLP-1 drugs) when they are prescribed solely for weight loss and not for any other medical conditions that the FDA has approved them for, the company said in a statement
